Kala Bio Inc (KALA)
7.07
+0.36
(+5.32%)
USD |
NASDAQ |
May 10, 16:00
7.07
0.00 (0.00%)
After-Hours: 19:19
Kala Bio Market Cap: 19.91M for May 10, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 09, 2024 | 18.91M |
| May 08, 2024 | 19.94M |
| May 07, 2024 | 19.49M |
| May 06, 2024 | 19.55M |
| May 03, 2024 | 19.74M |
| May 02, 2024 | 19.03M |
| May 01, 2024 | 19.18M |
| April 30, 2024 | 19.21M |
| April 29, 2024 | 19.29M |
| April 26, 2024 | 17.74M |
| April 25, 2024 | 17.41M |
| April 24, 2024 | 18.03M |
| April 23, 2024 | 18.49M |
| April 22, 2024 | 17.83M |
| April 19, 2024 | 18.56M |
| April 18, 2024 | 19.18M |
| April 17, 2024 | 19.26M |
| April 16, 2024 | 19.29M |
| April 15, 2024 | 19.72M |
| April 12, 2024 | 20.28M |
| April 11, 2024 | 20.28M |
| April 10, 2024 | 20.70M |
| April 09, 2024 | 20.87M |
| April 08, 2024 | 21.46M |
| April 05, 2024 | 21.41M |
| Date | Value |
|---|---|
| April 04, 2024 | 21.83M |
| April 03, 2024 | 21.91M |
| April 02, 2024 | 22.50M |
| April 01, 2024 | 22.50M |
| March 28, 2024 | 22.45M |
| March 27, 2024 | 21.66M |
| March 26, 2024 | 21.74M |
| March 25, 2024 | 21.83M |
| March 22, 2024 | 22.05M |
| March 21, 2024 | 22.08M |
| March 20, 2024 | 21.94M |
| March 19, 2024 | 21.30M |
| March 18, 2024 | 21.25M |
| March 15, 2024 | 20.78M |
| March 14, 2024 | 21.05M |
| March 13, 2024 | 21.11M |
| March 12, 2024 | 20.89M |
| March 11, 2024 | 21.58M |
| March 08, 2024 | 20.70M |
| March 07, 2024 | 20.23M |
| March 06, 2024 | 20.67M |
| March 05, 2024 | 20.63M |
| March 04, 2024 | 21.14M |
| March 01, 2024 | 20.23M |
| February 29, 2024 | 19.81M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
5.854M
Minimum
Dec 22 2022
768.31M
Maximum
Jun 02 2020
188.40M
Average
122.02M
Median
Market Cap Benchmarks
| CEL-SCI Corp | 76.65M |
| AIM ImmunoTech Inc | 20.13M |
| IGC Pharma Inc | 32.53M |
| NovaBay Pharmaceuticals Inc | 2.420M |
| Protalix BioTherapeutics Inc | 81.09M |
Market Cap Related Metrics
| PS Ratio | 2.990 |
| Price to Book Value | 2.654 |
| Price | 7.07 |
| Earnings Yield | -253.7% |